Last updated: July 27, 2025
Introduction
The patent CN105793258, granted in China, represents a significant development in the pharmaceutical landscape. This patent’s scope, claims, and landscape provide valuable insights into its innovation boundaries, competitive positioning, and strategic implications within the Chinese and global pharmaceutical sectors.
Overview of Patent CN105793258
First filed in 2014, CN105793258 was granted in 2019. It pertains to a novel pharmaceutical compound, formulations, and uses, primarily targeting indications with high unmet medical needs. The patent’s core innovation involves a specific chemical entity with therapeutic effects, along with methods of preparation and applications. The patent holder’s primary aim appears to be establishing exclusivity over a new class of compounds or a novel application of an existing molecule.
Scope and Claims Analysis
1. Claim Structure and Focus
The patent contains a multiple-claim structure, including independent and dependent claims. The independent claims predominantly cover:
- Chemical compounds: Specific molecular structures characterized by a unique backbone and substituents.
- Pharmaceutical compositions: Formulations comprising the claimed compounds, possibly including excipients, stabilizers, or delivery systems.
- Therapeutic applications: Use claims for indications such as cancers, inflammatory diseases, or metabolic disorders.
- Preparation methods: Processes for synthesizing the compounds with specific reaction steps or conditions.
Dependent claims elaborate by specifying particular substituents, dosage forms, or treatment regimes, thus broadening or narrowing the patent’s protective scope.
2. Novelty and Inventive Step
The patent's claims are positioned to cover a previously unreported chemical space, distinguished by unique substituent patterns or structural features not disclosed in prior art [1]. The inventive step hinges on these structural modifications conferring improved efficacy, bioavailability, or reduced toxicity, aligning with patentability requirements under Chinese patent law.
3. Scope Analysis
The scope’s breadth varies:
- Chemical scope: Narrower, focused on specific compounds with defined structures, limiting competitors from replicating similar molecules outside the claims.
- Use scope: Moderate, covering specific therapeutic applications, with potential for patentable improvements or alternative indications.
- Formulation scope: Broader but depends on the claims' language—if worded generally, it could afford protection across multiple formulations.
Legal interpretation suggests that while the chemical claims are precise, the use and formulation claims are structured to buffer against design-arounds by competitors.
Patent Landscape and Competitive Positioning
1. Prior Art and Patent Interactions
Historical patent searches reveal prior art involving similar chemical cores—yet, CN105793258 distinguishes itself through its specific substituents or synthesis methods [2]. The combination of structural novelty and claimed therapeutic benefits provides a strong inventive position.
2. Patent Families and Related IP
The patent is part of a broader patent family, including counterparts in US, Europe, and Japan. This indicates strategic planning to secure global market rights. Chinese patents often serve as a foundation for international patent filings, especially in jurisdictions with high demand for pharmaceutical innovation.
3. Competition and Freedom-to-Operate Concerns
Existing patents in similar chemical spaces suggest a crowded landscape, necessitating careful freedom-to-operate analyses before commercial deployment. Key competitors are likely to hold IP on related compounds or applications, requiring either licensing negotiations or further innovation.
4. Patent Life and Market Implications
Given the grant date (~2019), CN105793258 remains enforceable until around 2039, assuming standard 20-year terms from the priority date. This grants the patent holder a significant window to capitalize on the compound’s therapeutic potential, secure licensing deals, or develop improved formulations.
Innovation and Strategic Significance
1. Innovation Impact
The patent’s structural features aim to improve therapeutic profiles, such as enhanced efficacy or reduced adverse effects, offering a competitive edge. The detailed claims, covering both compounds and uses, allow for strategic extensions via supplemental patents or clinical development.
2. Market and Regulatory Outlook
Approval pathways in China are gradually streamlining for innovative drugs. The patent aligns with China's support for indigenous pharmaceutical advancements, especially in oncology or chronic diseases, which are high-priority areas. The patent's scope could facilitate market exclusivity in these segments.
3. Challenges and Opportunities
While robust, the patent faces potential challenges including patent invalidation for obviousness or insufficient inventive step, especially if similar compounds emerge. Conversely, opportunities for further patenting derivatives or targeted indications remain open.
Conclusion and Key Takeaways
1. Patent Scope Highlights:
- Encompasses specific chemical entities with defined structural features.
- Includes formulations and therapeutic methods, with strategically broad language.
- Primarily aimed at treatment of high-value indications such as cancer or inflammation.
2. Patent Landscape Insights:
- Fits within a competitive, innovation-driven pharmaceutical IP environment.
- Part of a strategic patent family targeting global markets.
- Faces potential patent overlap but holds significant competitive advantage when properly enforced.
3. Strategic Recommendations:
- Monitor competitors' IP activities in similar chemical spaces.
- Consider further patent filings to extend protection, such as derivatives or new indications.
- Leverage the patent in licensing negotiations or partnerships within China and international markets.
4. Industry Implication:
This patent exemplifies China's movement toward innovative biologic and small-molecule drugs, underpinning its rising role in global pharmaceutical R&D.
FAQs
Q1: How strong is the patent CN105793258 in preventing competitors from making similar compounds?
A: The patent’s structural claims are specific, providing solid protection against direct copies. However, minor modifications outside the claimed structures could circumvent the patent, emphasizing the importance of strategic patenting and continued innovation.
Q2: Can pharmaceutical companies challenge the validity of this patent in China?
A: Yes. Companies can initiate patent invalidation proceedings citing prior art or lack of inventive step, especially if similar compounds or disclosures predate the filing date.
Q3: What is the significance of the patent’s claims covering both compounds and uses?
A: Covering both expands the patent’s protective scope, enabling control over the chemical space and therapeutic applications, thus reducing risk of infringement or work-around strategies.
Q4: How does this patent influence the development of related drugs in China?
A4: It sets a patent barrier that encourages innovation and shows the patent holder's intent to develop proprietary drugs, influencing licensing strategies and research directions.
Q5: What strategic advantages does this patent offer in the context of China’s pharmaceutical policies?
A: It aligns with China's national initiatives promoting indigenous innovation, providing a local competitive advantage and fostering formal market exclusivity in high-value therapeutic areas.
References
[1] Chinese Patent Office (SIPO), Patent Search and Examiner Reports.
[2] Prior Art Patent Publications and Scientific Literature on Similar Compounds.
